Changsheng Bio-Technology Co. Ltd. (China): Fallout from the Vaccines Scandal
In 2018, Changsheng Bio-technology Co., Ltd. (Changsheng), a leading biopharmaceutical company and one of the market leaders in vaccines, was found to have falsified its production and inspection data and to have sold substandard vaccines in the Chinese market. The unethical conduct triggered widespread public anger and immediate government intervention. What actions could Changsheng take to mitigate the effect of this scandal? Thompson S.H. Teo is affiliated with National University of Singapore.